Gross Profit On Sales Cambiamento Data
Adma Biologics USD 63.33M 3.67M 2024-12
Alnylam Pharmaceuticals USD 490.35M 75.33M 2024-12
Dynavax Technologies USD 58.62M 8.92M 2024-12
Takeda JPY 727.25B 54.48B 2024-12



Adma Biologics Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.